Light and steroid treatment for vitiligo
Part of Skin clinical trials.
This study tests a combination of narrowband UVB light therapy and steroid cream to see how it affects the immune system in people with vitiligo. It may help reduce the white patches by calming the immune response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with non-segmental vitiligo (patches on both sides of the body) that has been stable for at least 3 months.
- Your skin type is III to V (common in Egyptian populations).
- You have not used any systemic (pill or injection) vitiligo treatments in the last 3 months.
- You do not have a condition that makes you sensitive to light, such as lupus or porphyria.
- You are not pregnant or breastfeeding.
- You have no active infections, cancer, or conditions that weaken the immune system.
- You do not have a history of raised scars (hypertrophic scars) or melanoma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment for non-segmental vitiligo that uses a special liquid made from stem cells, applied through tiny needle pricks or small injections, alongside standard light therapy. It may help restore pigment to white patches with fewer side effects than traditional treatments.
This study tests whether applying a strong steroid cream (betamethasone) with the help of ultrasound waves (phonophoresis) can repigment vitiligo patches. It aims to see if this combination works better than the cream alone.
This study tests whether adding a pill called apremilast to narrowband UVB light therapy works better than light therapy alone for vitiligo. It may help repigment the skin more effectively.
This study tests whether adding a short course of steroid pills (taken by mouth in a pulse pattern) to a skin-grafting procedure helps prevent a pale ring from forming around the treated spots in people with stable vitiligo. The procedure takes healthy, pigment-making skin cells from one area and applies them to the white patches.
This trial tests whether taking short courses of steroid pills alongside a skin cell transplant procedure helps treat stubborn vitiligo patches on the elbows and knees that have not improved with standard treatments.
This trial compares two types of needle treatments (needling and microneedling) combined with light therapy to see which works better for people with vitiligo that has lasted more than a year.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.